Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123
Phone: +1 858 450 2800
Website: SUDOSCAN.US
SUDOSCAN Int. / Impeto Medical
2 rue Maurice Hartmann,
92130 Issy Les Moulineaux
Phone: +33 (0)7 87 20 32 03
Website: Impeto Medical
DISCOVER SUDOSCAN®
An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy. Simple results obtained in 3 minutes.
SUDOSCAN® is a highly sensitive and reproducible tool for the early detection of peripheral neuropathy. Early detecting and follow-up of peripheral neuropathy could help monitor disease progression and assess treatment efficacy to improve patient management and control complications caused by diseases like diabetes.
SUDOSCAN® has developed a patented device & technology that assesses sudomotor function through sweat gland activity.
SUDOSCAN® Offers a simulation of the sweat glands that assess small nerve fibers
Diabetes
Neurology
Oncology
